{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T19:53:42Z","timestamp":1721159622638},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2014,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Atopic dermatitis (AD) is a multifactorial chronic inflammatory skin disease presenting with a relapsing clinical pattern similar to chronic autoimmune disease. Several human transglutaminases have been defined and keratinocyte transglutaminase (TG1) and epidermal transglutaminase (TG3) expressed in the epidermis are associated with epidermal barrier dysfunction. Since impairments to the epidermal barrier represent an important factor in AD, we hypothesized that IgA autoantibodies specific for TG1 (IgA-anti-TG1) and TG3 (IgA-anti-TG3) may affect AD development during childhood.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Active AD patients (n\u2009=\u2009304), 28 patients with biopsy-confirmed coeliac disease (CD), 5 patients with active AD and CD, and 55 control patients without CD and skin diseases were enrolled into the study. IgA-anti-TG1 and IgA-anti-TG3 reactivity was determined using an enzyme-linked immunosorbent assay. IgA-anti-TG2 were defined using a fluoroenzyme immunoassay.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>IgA-anti-TG1 antibodies were found in 2% and IgA-anti-TG3 antibodies in 3% of patients with active AD. Two out of the 5 patients with AD and concomitant CD had IgA-anti-TG1 and IgA-anti-TG2 antibodies. In CD patients, 36% of individuals presented with elevated IgA-anti-TG1 antibodies and 18% presented with elevated IgA-anti-TG3 antibodies and all CD patients presented with IgA-anti-TG2 antibodies (significantly different from AD patients and controls, p\u2009&lt;\u20090.05). In CD patients, IgA-anti-TG1 and\/or IgA-anti-TG3 seropositivity tended to appear concurrently, whereas only one patient with AD had both types of autoantibodies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>IgA-anti-TG1 and IgA-anti-TG3 seropositivity was rare in active AD but frequent in CD patients. The level of circulating antibodies related to skin lesions could be studied by determining the levels of IgA-anti-TG1 and IgA-anti-TG3 in skin biopsies of AD patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1756-0500-7-310","type":"journal-article","created":{"date-parts":[[2014,5,22]],"date-time":"2014-05-22T03:02:59Z","timestamp":1400727779000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Low prevalence of IgA anti-transglutaminase 1, 2, and 3 autoantibodies in children with atopic dermatitis"],"prefix":"10.1186","volume":"7","author":[{"given":"Krista","family":"Ress","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaupo","family":"Teesalu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Triine","family":"Annus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urve","family":"Putnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristi","family":"Lepik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin","family":"Luts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oivi","family":"Uibo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raivo","family":"Uibo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,22]]},"reference":[{"key":"2848_CR1","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1038\/jid.2009.133","volume":"129","author":"MJ Cork","year":"2009","unstructured":"Cork MJ, Danby SG, Vasilopoulos Y, Hadgraft J, Lane ME, Moustafa M, Guy RH, MacGowan AL, Tazi-Ahnini R, Ward SJ: Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol. 2009, 129: 1892-1908. 10.1038\/jid.2009.133.","journal-title":"J Invest Dermatol"},{"key":"2848_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jdermsci.2010.02.008","volume":"58","author":"Y Tokura","year":"2010","unstructured":"Tokura Y: Extrinsic and intrinsic types of atopic dermatitis. J Dermatol Sci. 2010, 58: 1-7. 10.1016\/j.jdermsci.2010.02.008.","journal-title":"J Dermatol Sci"},{"key":"2848_CR3","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1600-065X.2011.01027.x","volume":"242","author":"M Boguniewicz","year":"2011","unstructured":"Boguniewicz M, Leung DYM: Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev. 2011, 242: 233-246. 10.1111\/j.1600-065X.2011.01027.x.","journal-title":"Immunol Rev"},{"key":"2848_CR4","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.coi.2011.09.007","volume":"23","author":"N Novak","year":"2011","unstructured":"Novak N, Leung DYM: Advances in atopic dermatitis. Curr Opin Immunol. 2011, 23: 778-783. 10.1016\/j.coi.2011.09.007.","journal-title":"Curr Opin Immunol"},{"key":"2848_CR5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.it.2008.12.004","volume":"30","author":"R Valenta","year":"2009","unstructured":"Valenta R, Mittermann I, Werfel T, Garn H, Renz H: Linking allergy to autoimmune disease. Trends Immunol. 2009, 30: 109-116. 10.1016\/j.it.2008.12.004.","journal-title":"Trends Immunol"},{"key":"2848_CR6","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.jaci.2012.02.002","volume":"129","author":"TS Tang","year":"2012","unstructured":"Tang TS, Bieber T, Williams HC: Does \u201cautoreactivity\u201d play a role in atopic dermatitis. J Allergy Clin Immunol. 2012, 129: 1209-1215. 10.1016\/j.jaci.2012.02.002.","journal-title":"J Allergy Clin Immunol"},{"key":"2848_CR7","doi-asserted-by":"publisher","first-page":"e49694","DOI":"10.1371\/journal.pone.0049694","volume":"7","author":"A Lied\u00e9n","year":"2012","unstructured":"Lied\u00e9n A, Winge MCG, S\u00e4\u00e4f A, Kockum I, Ekelund E, Rodriquez E, F\u00f6lster-Holst R, Franke A, Illig T, Tengvall-Linder M, Baurecht H, Weidinger S, Wahlgren C-F, Nordenskj\u00f6ld M, Bradley M: Genetic variation in the epidermal transglutaminase genes is not associated with atopic dermatitis. PLoS ONE. 2012, 7: e49694-10.1371\/journal.pone.0049694.","journal-title":"PLoS ONE"},{"key":"2848_CR8","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1365-2133.2009.09156.x","volume":"161","author":"T Cheng","year":"2009","unstructured":"Cheng T, Tjabringa GS, van Vlijmen-Willems IM, Hitomi K, van Erp PE, Schalkwijk J, Zeeuwen PL: The cystatin M\/E-controlled pathway of skin barrier formation: expression of its key components in psoriasis and atopic dermatitis. Brit J Dermatol. 2009, 161: 253-264. 10.1111\/j.1365-2133.2009.09156.x.","journal-title":"Brit J Dermatol"},{"key":"2848_CR9","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1111\/j.1365-2133.2012.10885.x","volume":"166","author":"HD de Koning","year":"2012","unstructured":"de Koning HD, van den Bogaard EH, Bergboer JGM, Kamsteeg M, van Clijmen-Willems IMJJ, Hitomi K, Henry J, Simon M, Takashita N, Ishida-Yamamoto A, Schalkwijk J, Zeeuwen PLJM: Expression profile of cornified envelope structural proteins and keratinocyte differentiation-regulating proteins during skin barrier repair. Brit J Dermatol. 2012, 166: 1245-1254. 10.1111\/j.1365-2133.2012.10885.x.","journal-title":"Brit J Dermatol"},{"key":"2848_CR10","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.0022-202X.2005.23627.x","volume":"124","author":"RL Eckert","year":"2005","unstructured":"Eckert RL, Sturniolo MT, Broome A-M, Ruse M, Rorke EA: Transglutaminase function in epidermis. J Invest Dermatol. 2005, 124: 481-492. 10.1111\/j.0022-202X.2005.23627.x.","journal-title":"J Invest Dermatol"},{"key":"2848_CR11","doi-asserted-by":"publisher","first-page":"380","DOI":"10.4062\/biomolther.2012.20.4.380","volume":"20","author":"MK Park","year":"2012","unstructured":"Park MK, Cho SA, Lee HJ, Lee EJ, Kang JH, Kim YL, Kim HJ, Oh SH, Choi C, Lee H, Kim SY, Lee CH: Suppression of Transglutaminase-2 is Involved in Anti-Inflammatory Actions of Glucosamine in 12-O-Tetradecanoylphorbol-13-Acetate-Induced Skin Inflammation. Biomol Ther. 2012, 20: 380-385. 10.4062\/biomolther.2012.20.4.380.","journal-title":"Biomol Ther"},{"key":"2848_CR12","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/nm0797-797","volume":"3","author":"W Dieterich","year":"1997","unstructured":"Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, Schuppan D: Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med. 1997, 3: 797-801. 10.1038\/nm0797-797.","journal-title":"Nat Med"},{"key":"2848_CR13","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/MPG.0b013e31817d80f4","volume":"47","author":"C Lagerqvist","year":"2008","unstructured":"Lagerqvist C, Dahlbom I, Hansson T, Jidell E, Juto P, Olc\u00e9n P, Stenlund H, Hernell O, Ivarsson A: Antigliadin immunoglobulin A test in finding celiac disease in children younger than 18\u00a0months of age. J Pediatr Gastroenterol Nutr. 2008, 47: 428-435. 10.1097\/MPG.0b013e31817d80f4.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2848_CR14","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/MPG.0b013e31821a23d0","volume":"54","author":"S Husby","year":"2012","unstructured":"Husby S, Koletzko S, Korponay-Szab\u00f3 IR, Mearin ML, Phillips A, Shamir R, Troncone R, Giersiepen K, Branski D, Catassi C, Lelgeman M, M\u00e4ki M, Ribes-Koninckx C, Ventura A, Zimmer KP, ESPGHAN Working Group on Coeliac Disease Diagnosis; ESPGHAN Gastroenterology Committee; European Society for Pediatric Gastroenterology, Hepatology, and Nutrition: European Society for Pediatric Gastroenterology, Hepatology, and Nutrition Guidelines for the Diagnosis of Coeliac Disease. J Pediatr Gastroenterol Nutr. 2012, 54: 136-160. 10.1097\/MPG.0b013e31821a23d0.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2848_CR15","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1084\/jem.20011299","volume":"195","author":"M S\u00e1rdy","year":"2002","unstructured":"S\u00e1rdy M, K\u00e1rp\u00e1ti S, Merkl B, Paulsson M, Smyth N: Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J Exp Med. 2002, 195: 747-757. 10.1084\/jem.20011299.","journal-title":"J Exp Med"},{"key":"2848_CR16","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1365-2133.2008.08629.x","volume":"159","author":"CM Hull","year":"2008","unstructured":"Hull CM, Liddle M, Hansen N, Meyer LJ, Schmidt L, Taylor T, Jaskowski TD, Hill HR, Zone JJ: Elevation of IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis. Brit J Dermatol. 2008, 159: 120-124. 10.1111\/j.1365-2133.2008.08629.x.","journal-title":"Brit J Dermatol"},{"key":"2848_CR17","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1136\/adc.65.9.917","volume":"65","author":"JA Walker-Smith","year":"1990","unstructured":"Walker-Smith JA, Guandalini S, Schmitz J, Shmerling DH, Visakorpi JK: Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child. 1990, 65: 909-911.","journal-title":"Arch Dis Child"},{"key":"2848_CR18","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/0016-5085(92)91819-P","volume":"102","author":"MN Marsh","year":"1992","unstructured":"Marsh MN: Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (\u201cceliac sprue\u201d). Gastroenterology. 1992, 102: 330-354.","journal-title":"Gastroenterology"},{"key":"2848_CR19","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1542\/peds.2008-2373","volume":"124","author":"KE McGowan","year":"2009","unstructured":"McGowan KE, Castiglione DA, Butzner JD: The changing face of childhood celiac disease in North America: impact of serological testing. Pediatrics. 2009, 124: 1572-1578. 10.1542\/peds.2008-2373.","journal-title":"Pediatrics"},{"key":"2848_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cca.2009.01.006","volume":"403","author":"K Teesalu","year":"2009","unstructured":"Teesalu K, Agardh D, Panarina M, Utt M, Uibo O, Uibo R: A modified ELISA for improved detection of IgA, IgG, and IgM anti-tissue transglutaminase antibodies in celiac disease. Clin Chim Acta. 2009, 403: 37-41. 10.1016\/j.cca.2009.01.006.","journal-title":"Clin Chim Acta"},{"key":"2848_CR21","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/sj.jid.5701041","volume":"128","author":"EV Marietta","year":"2008","unstructured":"Marietta EV, Camilleri MJ, Castro LA, Krause PK, Pittelkow MR, Murray JA: Transglutaminase autoantibodies in dermatitis herpetiformis and celiac sprue. J Invest Dermatol. 2008, 128: 332-335.","journal-title":"J Invest Dermatol"},{"key":"2848_CR22","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1038\/jid.2009.142","volume":"129","author":"TD Jaskowski","year":"2009","unstructured":"Jaskowski TD, Hamblin T, Wilson A, Hill HR, Book LS, Meyer LJ, Zone JJ, Hull CM: IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis and pediatric celiac disease. J Invest Dermatol. 2009, 129: 2728-2730. 10.1038\/jid.2009.142.","journal-title":"J Invest Dermatol"},{"key":"2848_CR23","volume-title":"Clin Dev Immunol","author":"D Bonciani","year":"2012","unstructured":"Bonciani D, Verdelli A, Bonciolini V, D\u2019Errico A, Antiga E, Fabbri P, Caproni M: Dermatitis Herpetiformis: From the Genetics to the Development of Skin Lesions. Clin Dev Immunol. 2012, doi:10.1155\/2012\/239691"},{"key":"2848_CR24","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/ana.21450","volume":"64","author":"M Hadjivassiliou","year":"2008","unstructured":"Hadjivassiliou M, Aeshlimann P, Strigun A, Sanders DS, Woodrofe N, Aeschlimann D: Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase. Ann Neurol. 2008, 64: 332-343. 10.1002\/ana.21450.","journal-title":"Ann Neurol"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-7-310.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T04:10:59Z","timestamp":1630555859000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/1756-0500-7-310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,22]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2848"],"URL":"https:\/\/doi.org\/10.1186\/1756-0500-7-310","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,22]]},"assertion":[{"value":"20 June 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"310"}}